載入...

Everolimus plus exemestane versus bevacizumab-based chemotherapy for second-line treatment of hormone receptor-positive metastatic breast cancer in Greece: An economic evaluation study

BACKGROUND: The objective of our study was to conduct a cost-effectiveness (CE) study of combined everolimus (EVE) and exemestane (EXE) versus the common clinical practice in Greece for the treatment of postmenopausal women with HR+/HER2- advanced breast cancer (BC) progressing on nonsteroidal aroma...

全面介紹

Na minha lista:
書目詳細資料
發表在:BMC Health Serv Res
Main Authors: Kourlaba, Georgia, Rapti, Vasiliki, Alexopoulos, Athanasios, Relakis, John, Koumakis, Georgios, Chatzikou, Magdalini, Maniadakis, Nikos, Georgoulias, Vassilis
格式: Artigo
語言:Inglês
出版: BioMed Central 2015
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4524048/
https://ncbi.nlm.nih.gov/pubmed/26239115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12913-015-0971-4
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!